Mary J. Laughlin

8.3k total citations · 3 hit papers
111 papers, 5.7k citations indexed

About

Mary J. Laughlin is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Mary J. Laughlin has authored 111 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Hematology, 34 papers in Genetics and 29 papers in Molecular Biology. Recurrent topics in Mary J. Laughlin's work include Hematopoietic Stem Cell Transplantation (64 papers), Mesenchymal stem cell research (26 papers) and Immune Cell Function and Interaction (22 papers). Mary J. Laughlin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (64 papers), Mesenchymal stem cell research (26 papers) and Immune Cell Function and Interaction (22 papers). Mary J. Laughlin collaborates with scholars based in United States, Poland and Canada. Mary J. Laughlin's co-authors include Hillard M. Lazarus, John E. Wagner, Juliet N. Barker, Cladd E. Stevens, Omer N. Koç, Mary Eapen, Stanton L. Gerson, Richard E. Champlin, Mary M. Horowitz and Andromachi Scaradavou and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Mary J. Laughlin

109 papers receiving 5.5k citations

Hit Papers

Outcomes after Transplantation of Cord Blood or Bone Marr... 2001 2026 2009 2017 2004 2001 2005 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary J. Laughlin United States 35 3.5k 2.1k 1.5k 1.2k 1.1k 111 5.7k
Shunichi Kato Japan 43 3.0k 0.9× 1.1k 0.5× 2.2k 1.4× 1.4k 1.2× 956 0.9× 171 6.2k
Pablo Rubinstein United States 25 2.7k 0.8× 1.2k 0.5× 1.8k 1.2× 968 0.8× 815 0.7× 61 4.9k
Wolf‐Karsten Hofmann Germany 42 2.6k 0.8× 1.9k 0.9× 1.1k 0.8× 2.9k 2.5× 768 0.7× 251 6.7k
Richard A. Nash United States 48 4.9k 1.4× 1.1k 0.5× 2.7k 1.8× 833 0.7× 1.6k 1.4× 176 7.8k
Dagmar Dilloo Germany 29 1.1k 0.3× 1.5k 0.7× 1.4k 0.9× 1.2k 1.0× 1.4k 1.3× 92 4.7k
Edward F. Srour United States 43 3.0k 0.9× 1.5k 0.7× 2.0k 1.3× 2.9k 2.5× 1.8k 1.6× 165 7.2k
Cristina Navarrete United Kingdom 36 1.4k 0.4× 999 0.5× 1.3k 0.9× 877 0.8× 466 0.4× 120 4.4k
Curt I. Civin United States 49 3.4k 1.0× 1.4k 0.7× 1.7k 1.1× 4.9k 4.2× 2.0k 1.8× 202 9.3k
CI Civin United States 37 3.1k 0.9× 1.2k 0.6× 2.5k 1.7× 2.4k 2.1× 1.2k 1.1× 63 6.9k
Stephen G. Emerson United States 46 3.6k 1.1× 1.4k 0.7× 4.0k 2.6× 2.1k 1.8× 1.7k 1.6× 117 8.2k

Countries citing papers authored by Mary J. Laughlin

Since Specialization
Citations

This map shows the geographic impact of Mary J. Laughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary J. Laughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary J. Laughlin more than expected).

Fields of papers citing papers by Mary J. Laughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary J. Laughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary J. Laughlin. The network helps show where Mary J. Laughlin may publish in the future.

Co-authorship network of co-authors of Mary J. Laughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Mary J. Laughlin. A scholar is included among the top collaborators of Mary J. Laughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary J. Laughlin. Mary J. Laughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kindwall‐Keller, Tamila L., Howard Meyerson, Seunghee Margevicius, et al.. (2011). Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies. Bone Marrow Transplantation. 47(7). 924–933. 42 indexed citations
2.
Ratajczak, Janina, Ewa Zuba‐Surma, R Liu, et al.. (2011). Hematopoietic differentiation of umbilical cord blood-derived very small embryonic/epiblast-like stem cells. Leukemia. 25(8). 1278–1285. 44 indexed citations
3.
Passweg, Jakob, Mei-Jie Zhang, Vanderson Rocha, et al.. (2011). Donor Characteristics Affecting Graft Failure, Graft-versus-Host Disease, and Survival after Unrelated Donor Transplantation with Reduced-Intensity Conditioning for Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 17(12). 1869–1873. 25 indexed citations
4.
Eapen, Mary, John P. Klein, Guillermo Sanz, et al.. (2011). Effect of donor–recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. The Lancet Oncology. 12(13). 1214–1221. 134 indexed citations
5.
Eapen, Mary, Vanderson Rocha, Guillermo Sanz, et al.. (2010). Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. The Lancet Oncology. 11(7). 653–660. 397 indexed citations
6.
Brunstein, Claudio G. & Mary J. Laughlin. (2009). Extending Cord Blood Transplant to Adults: Dealing With Problems and Results Overall. Seminars in Hematology. 47(1). 86–96. 16 indexed citations
7.
Tse, William, Kevin D. Bunting, & Mary J. Laughlin. (2008). New insights into cord blood stem cell transplantation. Current Opinion in Hematology. 15(4). 279–284. 41 indexed citations
8.
Heeckeren, Willem J. van, Laura R. Fanning, Howard Meyerson, et al.. (2007). Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults. British Journal of Haematology. 139(3). 464–474. 21 indexed citations
9.
Greco, Nicholas J., Stephen E. Haynesworth, Joseph Martin, et al.. (2006). Direct Comparison of Umbilical Cord Blood versus Bone Marrow–Derived Endothelial Precursor Cells in Mediating Neovascularization in Response to Vascular Ischemia. Biology of Blood and Marrow Transplantation. 12(5). 585–593. 61 indexed citations
10.
Yüksel, Meltem Kurt, Elma D. Baron, Melissa Camouse, et al.. (2006). Peritransplant Use of Ultraviolet-B Irradiation (UV-B) Therapy Is Detrimental to Allogeneic Stem Cell Transplantation Outcome. Biology of Blood and Marrow Transplantation. 12(6). 665–671. 8 indexed citations
11.
Laughlin, Mary J., Mary Eapen, Pablo Rubinstein, et al.. (2005). Outcomes After Transplantation of Cord Blood or Bone Marrow From Unrelated Donors in Adults With Leukemia. Obstetrical & Gynecological Survey. 60(5). 295–296. 131 indexed citations
12.
Tse, William & Mary J. Laughlin. (2005). Cord blood transplantation in adult patients. Cytotherapy. 7(3). 228–242. 13 indexed citations
13.
Heeckeren, Willem J. van, Pingfu Fu, Brenda Cooper, et al.. (2005). Randomised comparison of two B‐cell purging protocols for patients with B‐cell non‐Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34+ cell enrichment device. British Journal of Haematology. 132(1). 42–55. 22 indexed citations
14.
Kleen, Thomas O., Suzanne Kadereit, Laura R. Fanning, et al.. (2005). Recipient-Specific Tolerance after HLA-Mismatched Umbilical Cord Blood Stem Cell Transplantation. Transplantation. 80(9). 1316–1322. 18 indexed citations
15.
Wadhwa, Punit D., Hillard M. Lazarus, Omer N. Koç, et al.. (2003). Hematopoietic recovery after unrelated umbilical cord-blood allogeneic transplantation in adults treated with in vivo stem cell factor (R-MetHuSCF) and filgrastim administration. Leukemia Research. 27(3). 215–220. 12 indexed citations
16.
Engelfriet, C. P., H. W. Reesink, John E. Wagner, et al.. (2002). International Forum. Vox Sanguinis. 83(2). 172–187. 5 indexed citations
17.
Kadereit, Suzanne, et al.. (2001). Cyclosporin A effects during primary and secondary activation of human umbilical cord blood T lymphocytes. Experimental Hematology. 29(7). 903–909. 20 indexed citations
18.
Laughlin, Mary J., Juliet N. Barker, Barbara Bambach, et al.. (2001). Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors. New England Journal of Medicine. 344(24). 1815–1822. 643 indexed citations breakdown →
19.
Laughlin, Mary J., David A. Rizzieri, Clayton A. Smith, et al.. (1998). Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia. Leukemia Research. 22(3). 215–219. 22 indexed citations
20.
Graham, Michael L., James E. Herndon, Joseph R. Casey, et al.. (1997). High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.. Journal of Clinical Oncology. 15(5). 1814–1823. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026